Literature DB >> 4404460

Digitalis toxicity: drug interactions promoting toxicity and the management of toxicity.

J T Bigger, H C Strauss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4404460

Source DB:  PubMed          Journal:  Semin Drug Treat        ISSN: 0091-6714


× No keyword cloud information.
  9 in total

1.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

2.  Assessment of the pharmacokinetic interaction between zileuton and digoxin in humans.

Authors:  W M Awni; Z Hussein; J H Cavanaugh; G R Granneman; L M Dubé
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

Review 3.  Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology.

Authors:  E M Antman; J M Arnold; P L Friedman; T W Smith
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

Review 4.  Drug interactions with digitalis glycosides.

Authors:  P F Binnion
Journal:  Drugs       Date:  1978-05       Impact factor: 9.546

Review 5.  Clinical pharmacology and therapeutics use of digitalis glycosides.

Authors:  J E Doherty; J J Kane
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 6.  Digitalis toxicity--turning over a new leaf?

Authors:  S J Bhatia
Journal:  West J Med       Date:  1986-07

7.  Anaesthetic problems associated with the treatment of cardiovascular disease: I. Digitalis toxicity.

Authors:  D C Chung
Journal:  Can Anaesth Soc J       Date:  1981-01

8.  [Clinical and pharmacokinetic studies in patients with digitalis intoxication (author's transl)].

Authors:  G Bodem; H J Gilfrich; H Aulepp; H Ochs; H J Dengler
Journal:  Klin Wochenschr       Date:  1977-01-01

Review 9.  Cardiac glycosides. Drug interactions of clinical significance.

Authors:  B Magnani; P L Malini
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.